PR86288

CALCI, Italy, October 28, 2020, /PRNewswire=KYODO JBN/--

First Procedures Performed with the Symani Surgical System

MMI SpA, an Italian company dedicated to improving clinical outcomes for

patients undergoing microsurgery, announced today the CE Mark, launch and first

human use of its Symani(R) Surgical System in Europe for open microsurgical

procedures. The first four robotic surgeries were successfully performed in

Florence, Italy, including three complex, post-traumatic lower limb

reconstructions as well as a post-oncological reconstruction of the pharynx.

"There is a clear demand for robotics in microsurgery as the limits of the

human hand have already been reached. We founded MMI to develop a robotic

system designed for and with microsurgeons that will improve outcomes and

address unmet patient needs, particularly through supermicrosurgery techniques

which are required for lymphatic and other extremely delicate procedures. We

are pleased to be at the forefront of a new era in robotic surgery as we launch our

Symani System in Europe," said Giuseppe Maria Prisco, co-founder and CEO of MMI.

The Symani Surgical System combines the benefits of tremor reduction and motion

scaling (7-20x) with the world's smallest wristed instrumentation, offering

seven degrees of freedom and dexterity beyond the reach of human hands. The

system's NanoWrist(R) instruments are designed to overcome the challenges of

free-flap reconstructions, replantations, congenital malformations, peripheral

nerve repairs and lymphatic surgery, which together represent over one million

procedures annually in the U.S. and Europe alone.

"Microsurgery and supermicrosurgery – as a tool, technique and discipline –

continue to evolve. The use of robotics holds great promise to advance the

specialty of microsurgery and improve care for patients affected by trauma,

cancer, congenital malformations and even chronic conditions such as

lymphedema," commented L. Scott Levin, MD, FACS, FAOA, Chair of the Department

of Orthopaedic Surgery, Professor of the Plastic Surgery Division at the

University of Pennsylvania School of Medicine, in response to the news of the

first clinical cases.

"We are proud to bring this innovation to European patients and look forward to

enabling surgeons worldwide to address challenging procedures on extremely

small anatomy with increased precision, reproducibility and efficiency," said

Hannah Teichmann, co-founder and Vice President of Clinical Development of MMI.

About MMI

Medical Microinstruments S.p.A. (MMI) was founded in 2015 near Pisa, Italy to

enhance surgical performance through the development of a robotic system that

enables surgeons to achieve better outcomes in microsurgery. The Symani

Surgical System combines proprietary innovations including the world's smallest

wristed microinstruments as well as tremor-reducing and motion scaling technologies.

Together, these powerful capabilities allow more surgeons to perform

microsurgery while expanding the field of supermicrosurgery. MMI is backed by

international medtech investors including Andera Partners, Panakes Partners,

Fountain Healthcare Partners and Sambatech.

Dr. Levin serves as a medical advisor to the company and has received financial

compensation from Medical Microinstruments S.p.A.

The MMI system for robotic microsurgery is currently only commercially

available in the European Economic Area. www.mmimicro.com

Photo - https://mma.prnewswire.com/media/1320169/Symani_MMI.jpg    

Logo - https://mma.prnewswire.com/media/1320170/MMI_Logo.jpg 

SOURCE: MMI SpA